Back
Colgate-Palmolive Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
74
CL
Colgate-Palmolive
Last Price:
$97.44
Seasonality Move:
3.6%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$99.75
Seasonality Move:
6.73%
Buy
74
Colgate-Palmolive (CL)
is a Buy
Is Colgate-Palmolive a Buy, Sell or Hold?
-
The current Colgate-Palmolive [CL] share price is $96.74. The Score for CL is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
CL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $103.03. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CL Stock Price Chart
What is Colgate-Palmolive's stock price today?
-
The Colgate-Palmolive share price today is $96.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CL is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $103.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
CL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.41 | Buy |
Relative Strength Index (14 RSI): | 69.47 | Buy |
Chaikin Money Flow: | 4207775 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.15 - 91.83) | Buy |
Bollinger Bands (100): | (88.12 - 96.28) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.04 | Sell |
Relative Strength Index (14 RSI): | 40.42 | Sell |
Chaikin Money Flow: | -321546 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.54 - 113.06) | Sell |
Bollinger Bands (100): | (110.42 - 127.2) | Sell |
CL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.15 | Buy |
20-day SMA: | 89.35 | Buy |
50-day SMA: | 89.17 | Buy |
200-day SMA: | 95.95 | Buy |
8-day EMA: | 92.55 | Buy |
20-day EMA: | 90.57 | Buy |
50-day EMA: | 90.31 | Buy |
200-day EMA: | 92.41 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.67 | Sell |
20-day SMA: | 107.25 | Sell |
50-day SMA: | 114.66 | Sell |
200-day SMA: | 126.84 | Sell |
8-day EMA: | 105.01 | Sell |
20-day EMA: | 107.54 | Sell |
50-day EMA: | 112.76 | Sell |
200-day EMA: | 121.2 | Sell |
Colgate-Palmolive Earnings Growth & CL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.03 per share, an increase this year of $0.14 per share, and an increase next year of $0.30 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
Colgate-Palmolive Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |